• Nemours Children’s Health partners with Beebe Health on cardiac care

    Jacksonville, Fla.-based Nemours Children's Health has opened a new cardiac specialty care clinic at Lewes, Del.-based Beebe Healthcare primary care facility in Selbyville, Del.
  • How health systems can meet the 'rising tide' of CVD: 5 notes

    Hospitals and health systems should be bracing for an 8% and 25% increase in demand for inpatient and outpatient cardiac procedures, respectively, over the next 10 years, according to a new report from Vizient analytic company, Sg2.
  • 10 highlights from American Heart Association's Scientific Sessions

    The American Heart Association held its annual Scientific Sessions Nov. 16-18 in Chicago, where healthcare organizations and industry leaders presented the latest research on cardiovascular health. 
  • Coronary artery calcium scores predict heart attack risk: 5 things to know

    Coronary artery calcium scores can accurately assess cardiovascular risk for both men and women, according to a study presented at the American Heart Association's annual Scientific Sessions Nov. 18. 
  • Number of cardiologists jumping to hospital practice doubles: Study

    Between 2008 and 2019, the share of cardiologists practicing in a hospital, as opposed to an independent practice, increased from 26% to 63%, according to a study published Nov. 15 in the Journal of the American College of Cardiology.
  • GLP-1 reduced heart failure risk by 46%: 8 study takeaways

    The GLP-1 tirzepatide, the active ingredient in Eli Lilly's Mounjaro, was found to reduce the risk of heart failure by 46% among individuals with obesity, according to a study published Nov. 16 in The New England Journal of Medicine and presented at the American Heart Association's annual Scientific Sessions.
  • Mass General Brigham names Heart and Vascular Institute leader

    Somerville, Mass.-based Mass General Brigham has appointed Patrick Ellinor, MD, PhD, as the inaugural executive director of the system's Heart and Vascular Institute.
  • Artificial heart saves 4th patient

    Surgeons at Cincinnati-based The Christ Hospital performed a successful human implantation of the BiVACOR Total Artificial Heart, marking the fourth hospital in the U.S. to complete the procedure as part of the FDA's early feasibility study.
  • FDA warns of arterial bypass device safety concerns: 5 things to know

    The FDA has warned providers of safety concerns and supply issues for Getinge/Maquet's VasoView HemoPro Endoscopic Vessel Harvesting Systems.
  • Donations continue for $265M heart institute

    Naples, Fla.-based NCH Healthcare System continues to receive donations for the system's $265 million heart institute, expected to open in 2027.
  • Hospitals with highest, lowest readmission rates for coronary bypass

    Tyler, Texas-based Christus Mother Frances Hospital had the lowest unplanned readmission rate for coronary artery bypass graft surgery in the U.S. between July 1, 2020, and July 30, 2023, according to CMS data released Oct. 30.
  • FDA guidelines overlooked for common blood clot device: 5 notes

    Designed to temporarily prevent blood clots from traveling to the lungs, approximately 85% of inferior vena cava filters inserted over an eight-year period were not removed, according to a study published Nov. 6 in JAMA.
  • 180% increase in obesity-related heart disease deaths: 8 notes

    Between 1999 and 2020, obesity-related deaths from heart disease deaths in the U.S. increased by 180%, according to a preliminary study to be presented at the American Heart Association's annual Scientific Sessions, set for Nov. 16-18. 
  • New stroke guidelines a 'huge step forward,' Northwestern cardiologist says

    The American Heart Association and American Stroke Association recently published updated guidelines for the prevention of stroke. Some of the key updates include the utilization of GLP-1 medications and an emphasis on prevention of stroke in women. 
  • GLP-1, SGLT2s lower mortality risk by 74% in stroke survivors: Study

    Stroke survivors who took GLP-1 or SGLT2 medications had a 74% lower risk of death, according to a preliminary study being presented at the American Heart Association's annual Scientific Sessions, set for Nov. 16-18. 
  • Hypertension in the US: 5 notes

    Nearly half of all adults in the U.S. had hypertension between August 2021 and 2023, though men were less likely to be aware of their status.
  • Top hospitals for stroke care: Healthgrades

    Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. 22. Of those, 99 hospitals were recognized for delivering superior clinical outcomes in the care and treatment of stroke.
  • 'A catalyst for change': Why Walmart heiress partnered with Cleveland Clinic, Mercy on cardiac care

    Cleveland Clinic, Chesterfield, Mo.-based Mercy and Bentonville, Ark.-based nonprofit organizations the Alice L. Walton Foundation and the Heartland Whole Health Institute have partnered to invest $700 million over 30 years to address the "$950 million lost annually" as patients leave Northwest Arkansas for specialty care, according to a Sept. 24 news release shared by Cleveland Clinic. 
  • The cancer-cardiology connection: 6 takeaways

    The annual Global Cardio-Oncology Summit was held in September, bringing together healthcare professionals in the context of cardiovascular disease and cancer. 
  • ECU Health leader named cardiology group president

    Greenville, N.C.-based ECU Health's director of cardiovascular disease management services, Stacey Greenway, was appointed president of the American Association of Cardiovascular and Pulmonary Rehabilitation.

Featured Whitepapers

Featured Webinars